These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28963455)

  • 1. Effects of Bacillus Calmette-Guérin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial.
    Birk NM; Nissen TN; Kjærgaard J; Hartling HJ; Thøstesen LM; Kofoed PE; Stensballe LG; Andersen A; Pryds O; Netea MG; Benn CS; Nielsen SD; Jeppesen DL
    Sci Rep; 2017 Sep; 7(1):12398. PubMed ID: 28963455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Bacillus Calmette-Guèrin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell].
    Taştan Y; Arvas A; Demir G; Alikaşifoğlu M; Gür E; Kiray E
    Pediatr Allergy Immunol; 2005 Dec; 16(8):624-9. PubMed ID: 16343082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of recombinant Balillus Calmette-Guerin secreting IL-12 vaccination on development of T cell subsets in neonatal BALB/c mice].
    He Y; Liu EM; Yang XQ; Li X; Liu W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):634-6. PubMed ID: 20108445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.
    Soares AP; Scriba TJ; Joseph S; Harbacheuski R; Murray RA; Gelderbloem SJ; Hawkridge A; Hussey GD; Maecker H; Kaplan G; Hanekom WA
    J Immunol; 2008 Mar; 180(5):3569-77. PubMed ID: 18292584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.
    Jones CE; Hesseling AC; Tena-Coki NG; Scriba TJ; Chegou NN; Kidd M; Wilkinson RJ; Kampmann B
    AIDS; 2015 Jan; 29(2):155-65. PubMed ID: 25535752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial.
    Jensen SK; Jensen TM; Birk NM; Stensballe LG; Benn CS; Jensen KJ; Pryds O; Jeppesen DL; Nissen TN
    Vaccine; 2020 Mar; 38(11):2449-2455. PubMed ID: 32057570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.
    Kiravu A; Osawe S; Happel AU; Nundalall T; Wendoh J; Beer S; Dontsa N; Alinde OB; Mohammed S; Datong P; Cameron DW; Rosenthal K; Abimiku A; Jaspan HB; Gray CM
    Front Immunol; 2019; 10():2307. PubMed ID: 31649662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial.
    Stensballe LG; Ravn H; Birk NM; Kjærgaard J; Nissen TN; Pihl GT; Thøstesen LM; Greisen G; Jeppesen DL; Kofoed PE; Pryds O; Sørup S; Aaby P; Benn CS
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):213-220. PubMed ID: 29635419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
    Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
    JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns.
    Birk NM; Nissen TN; Zingmark V; Kjærgaard J; Thøstesen LM; Kofoed PE; Stensballe LG; Andersen A; Nielsen SD; Benn CS; Pryds O; Jeppesen DL
    Pediatr Res; 2017 Jun; 81(6):873-880. PubMed ID: 28157835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A
    Pittet LF; Fritschi N; Tebruegge M; Dutta B; Donath S; Messina NL; Casalaz D; Hanekom WA; Britton WJ; Robins-Browne R; Curtis N; Ritz N
    Am J Respir Crit Care Med; 2022 Apr; 205(7):830-841. PubMed ID: 35007188
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.
    Kagina BM; Abel B; Bowmaker M; Scriba TJ; Gelderbloem S; Smit E; Erasmus M; Nene N; Walzl G; Black G; Hussey GD; Hesseling AC; Hanekom WA
    Vaccine; 2009 Sep; 27(40):5488-95. PubMed ID: 19616494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between the expression of perforin in T-lymphocyte subsets and antituberculosis in mice vaccinated with bacillus calmette-guerin].
    Lei JP; Wan Y; Zhou J; Wu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Oct; 33(10):771-4. PubMed ID: 21176510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Randomized Trials of the Effect of the Russian Strain of Bacillus Calmette-Guérin Alone or With Oral Polio Vaccine on Neonatal Mortality in Infants Weighing <2000 g in India.
    Jayaraman K; Adhisivam B; Nallasivan S; Krishnan RG; Kamalarathnam C; Bharathi M; McSharry B; Namachivayam SP; Shann F; Boopalan SI; David P; Bhat BV
    Pediatr Infect Dis J; 2019 Feb; 38(2):198-202. PubMed ID: 30256314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.
    Kang H; Yuan Q; Ma H; Hu ZD; Han DP; Wu K; Lowrie DB; Fan XY
    Immunology; 2014 Dec; 143(4):661-9. PubMed ID: 24965530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4⁺IL-17⁺TNF⁺IL-2⁺ T cells.
    Cruz A; Torrado E; Carmona J; Fraga AG; Costa P; Rodrigues F; Appelberg R; Correia-Neves M; Cooper AM; Saraiva M; Pedrosa J; Castro AG
    Vaccine; 2015 Jan; 33(1):85-91. PubMed ID: 25448107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gammadelta T cells in immunity induced by Mycobacterium bovis bacillus Calmette-Guérin vaccination.
    Lee J; Choi K; Olin MR; Cho SN; Molitor TW
    Infect Immun; 2004 Mar; 72(3):1504-11. PubMed ID: 14977956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
    Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
    JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.